November 19, 2014
The Ministry of Health, Labor and Welfare (MHLW) approved four pharmaceutical products on November 18, including Nippon Boehringer Ingelheim’s Spiriva (tiotropium bromide hydrate) for a new bronchial asthma indication. The three other products, along with Spiriva, are listed below.read more